The features of SONDELBAY® and its pen were selected with patients in mind1,2
SONDELBAY® offers people with osteoporosis a small and light-weight
device for self-injecting teriparatide, designed to be easy to handle:2
Compact and light-weight pen2
Side injection button3
Visible dose counter3
No priming needed3
No removing and replacing of cartridges3
Clear view of the drug solution in the pen once the pen cap is removed3
Maximum 3 days out-of-fridge stability at temperatures up to 25°C1
In-use stability demonstrated for 28 days at 2–8°C. Within the 28 days, the product can be stored at temperature conditions up to 25°C for a maximum of 3 days. Once opened, it may be stored for a maximum of 28 days at the above temperature conditions1
References:
1.SONDELBAY® Summary of Product Characteristics. 2. Data on file – UK-03873 (March 2022). Sondelbay Product Details.
3.SONDELBAY® Instructions for use.
SONDELBAY® (teriparatide) Summary of Product Characteristics (SmPC), legal category, cost and adverse event reporting:
By accessing www.sondelbay.co.uk and related website/pages (“the Site”) or by
otherwise accessing any content found on this site, you agree to the terms of our
Privacy Policy and the Terms of Use.